Stockreport

Board Changes [Yahoo! Finance]

Evotec SE  (EVO) 
NASDAQ:AMEX Investor Relations: eatonvance.com
PDF biopharmaceutical company pursuing a CLEVER approach to reprogramming myeloid cells to activate anti-tumor immunity in hematological and solid tumor microenvironments, i [Read more]